difficile toxin by enzyme immunoassay or cell ... or who were diagnosed with Crohn's disease or ulcerative colitis. Forty-eight patients were randomized to receive 50 mg (n = 16), 100 mg (n ...

It produces spores and allows all metabolic activity. Clostridium difficile (C. diff) is a type of bacteria that can cause ...

Purpose: Current and future treatment modalities for Clostridium difficile-associated disease (CDAD) are reviewed. Conclusion: CDAD is a major concern for health care systems and clinicians.